A D Voropaev studies the effectiveness of modified peptides, specifically a type called hevein-like peptide. This research is crucial as fungal infections are increasingly difficult to treat due to resistance against existing medications. Voropaev's work explores how these peptides can fight off various strains of fungi, prevent the formation of biofilms—which can make infections harder to treat—and safely interact with human cells. Overall, his research aims to produce new antifungal agents that can help patients suffering from these challenging infections.
Key findings
The modified hevein-like peptide mAc-AMP2 was effective against all tested strains of fungi at very low concentrations.
mAc-AMP2 prevented the formation of fungal biofilms, which are notoriously difficult to eradicate.
Importantly, mAc-AMP2 did not harm human cells, indicating its potential for safe use in new antifungal therapies.
Frequently asked questions
Does Dr. Voropaev study fungal infections?
Yes, Dr. Voropaev focuses specifically on developing treatments for fungal infections.
What treatments has Dr. Voropaev researched?
Dr. Voropaev has researched a modified peptide called mAc-AMP2 as a potential treatment against resistant fungal strains.
Is Dr. Voropaev's work relevant to patients with hard-to-treat fungal infections?
Absolutely. His research provides promising solutions for patients struggling with drug-resistant fungal infections.
Publications in plain English
Modified Hevein-like Peptide fromas a Promising Agent Against PathogenicSpecies.
2025
Pharmaceutics
Finkina EI, Gerasimova AA, Shevchenko OV, Bogdanov IV, Tagaev AA +2 more
Plain English Researchers studied a modified version of a peptide called hevein-like peptide, known as mAc-AMP2, to see if it could effectively fight off fungal infections, which are becoming harder to treat because fungi are developing resistance to existing treatments. They found that mAc-AMP2 was effective against all tested strains of fungi at very low concentrations and could prevent fungi from forming troublesome biofilms. Importantly, it did not harm human cells, making it a promising candidate for new antifungal therapies.
Who this helps: This benefits patients suffering from fungal infections and healthcare providers seeking effective treatments.
Effects of the Tobacco Defensin NaD1 Against Susceptible and Resistant Strains of.
2024
Pathogens (Basel, Switzerland)
Shevchenko OV, Voropaev AD, Bogdanov IV, Ovchinnikova TV, Finkina EI
Plain English This study investigated the effects of a tobacco protein called NaD1 on various strains of fungus that cause infections, both those that can be treated with current medications and those that are resistant. Researchers found that NaD1 was effective at killing all tested fungal strains at concentrations of 6.25 and 12.5 micromolar. The findings are significant because NaD1 worked well not only on its own but also boosted the effectiveness of other antifungal treatments, suggesting it could be a new option for treating stubborn fungal infections.
Who this helps: Patients suffering from fungal infections, especially those with resistant strains.
Immunomodulatory Effects of the Pea Defensin Psd1 in the Caco-2/Immune Cells Co-Culture uponInfection.
2023
International journal of molecular sciences
Bogdanov IV, Fateeva SI, Voropaev AD, Ovchinnikova TV, Finkina EI
Plain English This study looked at how a protein from peas, called Psd1, can help the immune system fight off fungal infections, specifically candidiasis, which is dangerous for people with weakened immune systems. Researchers found that Psd1 could effectively reduce inflammation and help the body mount a better immune response when faced with infection, even at low concentrations. This is important because it suggests that Psd1 could be a valuable treatment not just for the fungus itself, but also for managing the harmful immune reactions that accompany infections.
Who this helps: Patients at risk for severe fungal infections, particularly those with weakened immune systems.
Antifungal Activity, Structural Stability, and Immunomodulatory Effects on Human Immune Cells of Defensin from the Lentil.
2022
Membranes
Finkina EI, Bogdanov IV, Ignatova AA, Kanushkina MD, Egorova EA +3 more
Plain English This study focused on a protein called Lc-def, found in lentil seeds, which has antifungal properties. Researchers discovered that Lc-def effectively inhibited the growth of certain harmful fungi by about 50% at concentrations of 25-50 micromolar and was safe for human cells. Additionally, Lc-def was stable during digestion and helped boost immune response by increasing key immune signals linked to fighting fungal infections.
Who this helps: This benefits patients at risk of fungal infections, particularly those with weakened immune systems.
[Discriminant analysis in establishing the relationship of pathogenetic mechanisms of gestational complications in urogenital infection in pregnant women.].
2020
Klinicheskaia laboratornaia diagnostika
Karaulov AV, Afanasiev SS, Zatevalov AM, Nesvizhsky YV, Voropaeva EA +7 more
Plain English This study looked at how the immune system's response to infections affects pregnant women with urogenital infections. Researchers examined 89 women and found that higher levels of mucosal immunity were linked to less severe infections and fewer symptoms related to miscarriage. This is important because it highlights the need to understand immune responses in pregnant women, which can improve management and outcomes for those experiencing infections during pregnancy.
Who this helps: This helps pregnant women with urogenital infections and their healthcare providers.
[Efficacy of laboratory methods of diagnostic of purulent bacterial meningitis.].
2019
Klinicheskaia laboratornaia diagnostika
Oganesyan AN, Voropaeva EA, Mel'nikova AA, Mironov AY, Egorova EA +4 more
Plain English This study examined different laboratory methods for diagnosing purulent bacterial meningitis (PBM) in Europe and Asia between 2010 and 2017. The researchers tested 2,893 samples and found that PCR tests were significantly more effective than traditional culture methods—detecting Neisseria meningitidis 5 times more effectively, Streptococcus pneumoniae 3 times more, and Haemophilus influenzae 4 times more. This is important because faster and more accurate diagnoses can lead to better treatment and improved outcomes for patients.
Who this helps: This helps patients and doctors by ensuring quicker and more accurate diagnoses of bacterial meningitis.